Baiyunshan (00874.HK) (600332.SH) announced that its subsidiary pharmaceutical plant recently received the "Pharmaceutical Production License" issued by the Guangdong Provincial Pharmaceutical Supervision and Administration Bureau, approving the addition of production address, production workshop, production line, and production scope to the chemical pharmaceutical plant, and passing the inspection of pharmaceutical production quality management norms.

The group believes that the addition of production address, production workshop, production line, and production scope to the chemical pharmaceutical plant, and passing the inspection of pharmaceutical production quality management norms, will help increase its production capacity, improve production efficiency, enhance automation and digitization levels, and meet market demand. The acquisition of the "Pharmaceutical Production License" this time will not have a significant impact on the company's current performance.